Hepion Pharmaceuticals, Inc.
HEPA
$0.3187
$0.02127.13%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M |
| Total Depreciation and Amortization | 0.00 | 0.00 | 0.00 | 30.80K | 12.30K |
| Total Amortization of Deferred Charges | 794.20K | 474.60K | -- | -- | -- |
| Total Other Non-Cash Items | -444.00K | -38.30K | -4.50M | 1.34M | 3.99M |
| Change in Net Operating Assets | 44.30K | 1.91M | -2.50M | -2.14M | -1.94M |
| Cash from Operations | -1.15M | -2.52M | -10.93M | -3.62M | -9.00M |
| Capital Expenditure | -- | -- | -- | -- | -300.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -600.00K | -- | -- | -- |
| Cash from Investing | 0.00 | -600.00K | -- | -- | -300.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 2.50M | 0.00 | 1.85M | 4.50M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 2.50M | 0.00 | 1.85M | 4.50M |
| Foreign Exchange rate Adjustments | 62.20K | 0.00 | -61.80K | 86.70K | 9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.09M | -617.90K | -10.99M | -1.68M | -4.50M |